Revenue
$230.2m
+7.9% ↑ vs $213.2m
A 3.1% effective tax rate flattered NPAT to a 120% gain while OCF/EBITDA fell to 79.2% from 145.7% on working-capital normalisation.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY25 vs FY24
Revenue
$230.2m
+7.9% ↑ vs $213.2m
EBITDA
$27.8m
+17.7% ↑ vs $23.6m
Net profit after tax
$20.9m
+120.0% ↑ vs $9.5m
Net cash inflow from operating activities
$22m
-36.0% ↓ vs $34.4m
Profit before tax
$20.2m
+38.4% ↑ vs $14.6m
Cash and cash equivalents
$84.8m
+27.2% ↑ vs $66.7m
Total assets
$324.8m
+12.9% ↑ vs $287.7m
What changed
Reported NPAT of $20.9m was up 120.0%, but that headline is amplified by a 3.1% effective tax rate against 34.7% in FY24; PBT growth of 38.4% is the cleaner operating read.
Revenue rose 8.0% to $230.2m and EBITDA grew 17.7% to $27.8m, signalling positive operating leverage at the EBITDA line. The Utility segment delivered $193.4m (84.0% of revenue) at a disclosed 10.5% segment gross margin, with Airport revenue rising to $36.8m. The balance sheet strengthened: cash rose to $84.8m, gross borrowings remained at zero, and equity grew 17.5% to $244.2m. No dividend was declared.
What matters
OCF/EBITDA fell to 79.2% from 145.7%, and operating working capital declined $17.7m year-on-year (from $28.6m to $10.9m), which means the prior-year cash result was lifted by an unusually large working-capital release that did not repeat. For an investor, the implication is that FY24 OCF was not a fair baseline; FY25 conversion of 79.2% is closer to what underlying earnings actually produce in cash, and FCF/NPAT of 97.1% (versus 349.0% in FY24) confirms the same point.
Tax distortion is masking the operating result. The effective tax rate of 3.1% drove an 81.6 percentage-point gap between NPAT growth (120.0%) and PBT growth (38.4%). The 38.4% PBT lift is real and is supported by EBITDA up 17.7% on revenue up only 8.0%, but the 120.0% NPAT figure is not repeatable at a normalised tax rate and should not be extrapolated.
Net cash position deepened despite weaker conversion. Cash rose $18.1m to $84.8m with no drawn debt and capex of just 0.8% of revenue, so net cash to EBITDA strengthened to -3.05x from -2.83x. The implication: financial flexibility for R&D, g2.0 platform investment, or M&A is intact, but capital is sitting on the balance sheet rather than being returned, with no dividend declared.
Expectations
The release notes results are "in line with guidance" and that recurring revenue grew 13%, but a specific quantitative target is not provided, so the briefing cannot test the result against a stated bar.
The HY25 split shows the year was second-half weighted: H1 contributed 48.7% of revenue, 46.6% of EBITDA and only 34.4% of NPAT. That implied H2 NPAT of $13.7m versus H1 of $7.2m is partly mechanical given the year's low effective tax rate, so the H2 acceleration in reported earnings should not be read as evidence of accelerating underlying profitability without further disclosure on the tax outcome.
Quality of result
Revenue grew 8.0% while EBITDA grew 17.7% and PBT grew 38.4%, with capex held to 0.8% of revenue and receivable days improving slightly to 45.3 from 48.0. ROE roughly doubled to 8.6% from 4.6%, though part of that uplift reflects the same tax effect that flattered NPAT.
The cash and tax lines are lower quality. The 36.0% drop in operating cash flow reflects the unwind of a $17.7m working-capital tailwind that boosted FY24 OCF to 145.7% of EBITDA, so the FY24 cash base was overstated relative to underlying earnings. Equally, the 3.1% effective tax rate is not explained in the supplied excerpts and is unlikely to recur at that level. A normalised tax rate applied to the same PBT would produce materially lower NPAT than the $20.9m reported.
Unresolved
This briefing cannot assess the durability of the FY25 tax outcome or management's forward EBITDA, margin, or capital-return intentions because no quantitative targets, tax commentary, or dividend policy statement were provided in the release excerpts.
Chat
Ask follow-up questions about Gentrack Group's FY25 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
FY25 Financial Statements
FY25 / financial reportInvestor Presentation
FY25 / results presentationMarket Announcement
FY25 / results releaseResults Announcement
FY25 / results announcementFY24 Financial Statements
FY24 / financial reportMarket Announcement
FY24 / results releaseResults Announcement
FY24 / results announcement1HFY25 Market Announcement
HY25 / results release1HFY25 Results Announcement
HY25 / results announcementInterim Financial Statements March 2025
HY25 / financial reportAnnual Results - Investor Briefing
FY25 / commentaryGTK Strategy Day Presentation
FY25 / commentaryMarket Update 25 July 2025
FY25 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 79.2% of EBITDA to operating cash flow, -66.5pp versus the prior comparable period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 81.6pp, with a distortion flag in the result.
Leverage and balance-sheet risk
Net debt / EBITDA is -3.05x, -0.22x versus the prior comparable period.
Revenue growth context
Revenue growth was 8.0% for this reporting period.
Get the next Gentrack Group briefing and related NZX reporting-season updates by email.